Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

2
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

5
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
5
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

522
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
522
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

2
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
2
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

7
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
7

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutaneous embryology: Physiological basis and clinical implications.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

A Real-World Cross-Sectional Study on Suspected Mast Cell Activation Syndrome: Multiple Heterogeneous Symptoms Identified.

Clinical and translational allergy·2026
Same author

Biomarkers in atopic dermatitis: Current evidence and unmet needs.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Treatment Approaches for Omalizumab-Refractory Chronic Spontaneous Urticaria.

Journal of inflammation research·2026
Same author

European Society of Contact Dermatitis Guideline for Diagnostic Patch Testing-Recommendations on Best Practice (Update 2026).

Contact dermatitis·2026
Same author

Expert Consensus on the Management of Hyperpigmentation Disorders in India: A Modified Delphi Study by the Pigmentary Disorders Society.

International journal of dermatology·2026

Related Experiment Video

Updated: Jun 7, 2025

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

4.7K

Managing Urticarial Vasculitis: A Clinical Decision-Making Algorithm Based on Expert Consensus.

Nikolai Dario Rothermel1, Carolina Vera Ayala1,2, Margarida Gonçalo3,4

  • 1Institute of Allergology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Hindenburgdamm 27, 12203, Berlin, Germany.

American Journal of Clinical Dermatology
|November 13, 2024
PubMed
Summary
This summary is machine-generated.

Urticarial vasculitis (UV) management lacks guidelines. This review proposes a treatment algorithm based on the Urticarial Vasculitis Activity Score (UVAS7), guiding clinicians on systemic therapies for this rare condition.

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.5K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.1K

Related Experiment Videos

Last Updated: Jun 7, 2025

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

4.7K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.5K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.1K

Area of Science:

  • Dermatology
  • Rheumatology
  • Immunology

Background:

  • Urticarial vasculitis (UV) is a rare, challenging small-vessel vasculitis characterized by persistent wheals.
  • Current clinical management of UV lacks established guidelines and treatment algorithms.
  • Effective treatment strategies are crucial due to UV's potential for severe manifestations.

Purpose of the Study:

  • To review existing evidence on systemic treatments for urticarial vasculitis.
  • To propose a novel clinical decision-making algorithm for UV management.
  • To stratify treatment based on disease severity using the Urticarial Vasculitis Activity Score (UVAS7).

Main Methods:

  • Systematic review of evidence for systemic UV treatments.
  • Development of a treatment algorithm incorporating the UVAS7.
  • Categorization of UV based on skin-limited or systemic involvement and severity.

Main Results:

  • Mild UV (UVAS7 ≤7) may be managed with chronic urticaria protocols (antihistamines, omalizumab, cyclosporine A).
  • Severe UV (UVAS7 >7) or hypocomplementemic UV often requires a multidisciplinary approach and immunomodulatory therapies (corticosteroids, dapsone, etc.).
  • Evidence supporting current UV treatments is generally low, necessitating further research.

Conclusions:

  • A proposed UVAS7-based algorithm can aid clinicians in managing urticarial vasculitis.
  • Treatment selection depends on disease severity, clinical presentation, and potential underlying conditions.
  • Further prospective studies are essential to improve understanding and treatment of UV.